Edmond Chen

5.0k citations

22 papers · 603 indexed · h-index 11

Impact in

Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 5%
- Cardiac electrophysiology and arrhythmias
- Antiplatelet Therapy and Cardiovascular Diseases
- ECG Monitoring and Analysis
- Acute Myocardial Infarction Research
- Atrial Fibrillation Management and Outcomes

Papers in ⓘ

Internal Medicine 5
- Venous Thromboembolism Diagnosis and Management 5
Cardiology and Cardiovascular Medicine 19
- Antiplatelet Therapy and Cardiovascular Diseases 15
- Acute Myocardial Infarction Research 12
- Atrial Fibrillation Management and Outcomes 8
- Cardiac electrophysiology and arrhythmias 1

Co-authors: Franz Xaver Roithinger (1 shared paper)Andrew J Sands (1 shared paper)Laura Rodríguez Chávez (1 shared paper)Philippe Maury (1 shared paper)Jonathan M. Kalman (1 shared paper)Andrew D. Krahn (1 shared paper)Pedro Iturralde Torres (1 shared paper)David Zeltser (1 shared paper)
Journals: Circulation (6 papers)American Heart Journal (4 papers)The American Journal of Cardiology (3 papers)Academic Emergency Medicine (2 papers)European Heart Journal Acute Cardiovascular Care (1 paper)
Partner nations: United States Canada Australia

In The Last Decade

Edmond Chen

22 papers receiving 574 citations

Peers

Countries citing papers authored by Edmond Chen

Since Specialization

Citations

This map shows the geographic impact of Edmond Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond Chen more than expected).

Fields of papers citing papers by Edmond Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmond Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond Chen. The network helps show where Edmond Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Edmond Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edmond Chen Line = papers co-authored together Edmond Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see one Heart Rhythm ·Sami Viskin, Uri Rosovski, Andrew J Sands, Edmond Chen, Peter M. Kistler, Jonathan M. Kalman, Laura Rodríguez Chávez, Pedro Iturralde Torres, Fernando E.S. Cruz F., Osmar Antonio Centurión, Akira Fujiki, Philippe Maury, Xiaohong Chen, Andrew D. Krahn, Franz Xaver Roithinger, Li Zhang, G. Michael Vincent, David Zeltser	2005	274
2	Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD) American Heart Journal ·Warren H. Capell, Marc P. Bonaca, Mark R. Nehler, Edmond Chen, John M. Kittelson, Sonia S. Anand, Scott D. Berkowitz, E. Sebastian Debus, Fabrizio Fanelli, Lloyd Haskell, Manesh R. Patel, Rupert Bauersachs, William R. Hiatt	2018	84
3	The Association between White Blood Cell Count and Acute Myocardial Infarction In‐hospital Mortality: Findings from the National Registry of Myocardial Infarction Academic Emergency Medicine ·Mary Grzybowski, Robert D. Welch, Lori Parsons, Chiadi E. Ndumele, Edmond Chen, Robert J. Zalenski, Hal V. Barron	2004	53
4	Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) American Heart Journal ·W. Schuyler Jones, Pierluigi Tricoci, Zhen Huang, David J. Moliterno, Robert A. Harrington, Peter Sinnaeve, John Strony, Frans Van de Werf, Harvey D. White, Claes Held, Paul W. Armstrong, Philip E. Aylward, Edmond Chen, Manesh R. Patel, Kenneth W. Mahaffey	2014	43
5	Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes Thrombosis and Haemostasis ·Robert F. Storey, Jayaprakash Kotha, Susan S. Smyth, David J. Moliterno, Tyrus Rorick, Tiziano Moccetti, Marco Valgimigli, Jean Pierre Dery, Jan H. Cornel, Gregory S. Thomas, Kurt Huber, Robert A. Harrington, Edward Hord, Heather M. Judge, Edmond Chen, John Strony, Kenneth W. Mahaffey, Pierluigi Tricoci, Richard C. Becker, Lisa K. Jennings	2014	22
6	Usefulness and Safety of Vorapaxar in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention (from the TRACER Trial) The American Journal of Cardiology ·Marco Valgimigli, Pierluigi Tricoci, Zhen Huang, Philip E. Aylward, Paul W. Armstrong, Frans Van de Werf, Sergio Leonardi, Harvey D. White, Petr Widimský, Robert A. Harrington, Ángel Cequier, Edmond Chen, Yuliya Lokhnygina, Lars Wallentin, John Strony, Kenneth W. Mahaffey, David J. Moliterno	2014	17
7	The Association between White Blood Cell Count and Acute Myocardial Infarction In-hospital Mortality: Findings from the National Registry of Myocardial Infarction Academic Emergency Medicine ·Mary Grzybowski, Robert D. Welch, Lori Parsons, Chiadi E. Ndumele, Edmond Chen, Robert J. Zalenski, Hal V. Barron	2004	17
8	Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial) The American Journal of Cardiology ·Kenneth W. Mahaffey, Zhen Huang, Lars Wallentin, Robert F. Storey, Lisa K. Jennings, Pierluigi Tricoci, Harvey D. White, Paul W. Armstrong, Philip E. Aylward, David J. Moliterno, Frans Van de Werf, Edmond Chen, Sergio Leonardi, Tyrus Rorick, Claes Held, John Strony, Robert A. Harrington	2013	16
9	Vorapaxar with or without clopidogrel after non–ST-segment elevation acute coronary syndromes: Results from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome trial American Heart Journal ·Pierluigi Tricoci, Yuliya Lokhnygina, Zhen Huang, Frans Van de Werf, Jan H. Cornel, Edmond Chen, Lars Wallentin, Claes Held, Philip E. Aylward, David J. Moliterno, Lisa K. Jennings, Harvey D. White, Paul W. Armstrong, Robert A. Harrington, John Strony, Kenneth W. Mahaffey	2014	16
10	Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non–ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial) The American Journal of Cardiology ·Jan H. Cornel, Pierluigi Tricoci, Yuliya Lokhnygina, David J. Moliterno, Lars Wallentin, Paul W. Armstrong, Philip E. Aylward, Robert M. Clare, Edmond Chen, Sergio Leonardi, Frans Van de Werf, Harvey D. White, Claes Held, John Strony, Kenneth W. Mahaffey, Robert A. Harrington	2015	15
11	Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial European Heart Journal Acute Cardiovascular Care ·Claes Held, Pierluigi Tricoci, Zhen Huang, Frans Van de Werf, Harvey D. White, Paul W. Armstrong, Giuseppe Ambrosio, Philip E. Aylward, David J. Moliterno, Lars Wallentin, Edmond Chen, Aycan Fahri Erkan, Lixin Jiang, John Strony, Robert A. Harrington, Kenneth W. Mahaffey	2014	14
12	Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial Clinical Trials ·Brigitte Kendall, Reto Städeli, Belinda Schegg, Martin Olbrich, Edmond Chen, Rona Harmelin-Kadouri, Peter Aurup, Tilmann Schwab, Steven Hildemann	2012	7
13	Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial American Heart Journal ·Luciana Armaganijan, Karen P. Alexander, Zhen Huang, Pierluigi Tricoci, Claes Held, Frans Van de Werf, Paul W. Armstrong, Philip E. Aylward, Harvey D. White, David J. Moliterno, Lars Wallentin, Edmond Chen, Robert A. Harrington, John Strony, Kenneth W. Mahaffey, Renato D. Lópes	2016	6
14	Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar Catheterization and Cardiovascular Interventions ·Jean‐Pierre Déry, Kenneth W. Mahaffey, Pierluigi Tricoci, Harvey D. White, Mohua Podder, Cynthia M. Westerhout, David J. Moliterno, Robert A. Harrington, Edmond Chen, John Strony, Frans Van de Werf, Khaled M. Ziada, Claes Held, Philip E. Aylward, Paul W. Armstrong, Sunil V. Rao	2015	6
15	EFFECTS OF GLYCOPROTEIN IIB/IIIA INHIBITORS IN COMBINATION WITH VORAPAXAR, A PLATELET THROMBIN-RECEPTOR ANTAGONIST, AMONG PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE TRACER TRIAL Journal of the American College of Cardiology ·Jan H. Cornel, Pierluigi Tricoci, J.R. Horton, David J. Moliterno, Lars Wallentin, Paul W. Armstrong, Philip E. Aylward, Zhen Huang, Yuliya Lokhnygina, Edmond Chen, Sergio Leonardi, Frans Van de Werf, Harvey D. White, Claes Held, John Strony, Kenneth W. Mahaffey, Robert A. Harrington	2013	3
16	CYP2C19 Polymorphism and PON-1 Activity in NSTE ACS : Vorapaxar Effect in Relation to Clopidogrel Metabolism in the TRACER Trial Circulation ·Pierluigi Tricoci, Edmond Chen, Megan L. Neely, Amelia Warner, Peggy H. Wong, Peter Sinnaeve, Lars Wallentin, Lisa K. Jennings, Robert F. Storey, Philip E. Aylward, Harvey D. White, Frans Van de Werf, Paul W. Armstrong, Claes Held, Marco Valgimigli, Robert A. Harrington, John Strony, Kenneth W. Mahaffey, David J. Moliterno	2013	2
17	Abstract 18805: Vorapaxar, A Platelet Thrombin-Receptor Antagonist, in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from the TRACER Trial Circulation ·Marco Valgimigli, Pierluigi Tricoci, Zhen Huang, Philip E. Aylward, Paul W. Armstrong, Harvey D. White, Petr Widimský, Robert A. Harrington, Ángel Cequier, Khaled M. Ziada, Yung‐Ming Chen, Edmond Chen, Yuliya Lokhnygina, Lars Wallentin, John Strony, Kenneth W. Mahaffey, David J. Moliterno	2012	2
18	Electrifying Change : An Analysis of Streetlight Electric Vehicle Charging Around Multi-Family Residential Units in Vancouver Open Collections ·Justin Mirabilis Haw, Edmond Chen, Xizhen Wang, Matthew T. Loveland	2021	2
19	Efficacy and Safety of Vorapaxar in Elderly Patients With Non-ST-Segment Elevation Acute Coronary Syndrome : Insights From the TRACER Trial Circulation ·Luciana Armaganijan, Renato D. Lópes, Zhen Huang, Pierluigi Tricoci, Claes Held, Frans Van de Werf, Paul W. Armstrong, Philip E. Aylward, Harvey D. White, David J. Moliterno, Lars Wallentin, Edmond Chen, Robert A. Harrington, John Strony, Kenneth W. Mahaffey	2013	1
20	Abstract 17939: Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Peripheral Artery Disease: Results From TRACER Circulation ·Schuyler Jones, Pierluigi Tricoci, Zhen Huang, David J. Moliterno, Robert A. Harrington, Peter Sinnaeve, John Strony, Frans Van de Werf, Harvey D. White, Claes Held, Paul W. Armstrong, Philip E. Aylward, Edmond Chen, Manesh R. Patel, Kenneth W. Mahaffey	2013	1

About Edmond Chen

Edmond Chen is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Clinical Biochemistry, Pharmacology and Surgery, having authored 22 papers that have together received 603 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (15 papers), Acute Myocardial Infarction Research (12 papers), Atrial Fibrillation Management and Outcomes (8 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Coronary Interventions and Diagnostics (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Peripheral Artery Disease Management (2 papers) and Cardiac electrophysiology and arrhythmias (1 paper). The work is most often cited by research in Internal Medicine (92 citations), Cardiology and Cardiovascular Medicine (512 citations), Hematology (64 citations), Surgery (151 citations) and Pulmonary and Respiratory Medicine (67 citations). Edmond Chen has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Franz Xaver Roithinger, Andrew J Sands, Laura Rodríguez Chávez, Philippe Maury, Jonathan M. Kalman, Andrew D. Krahn, Pedro Iturralde Torres, David Zeltser, Sami Viskin and Akira Fujiki. Their work appears in journals such as Circulation, American Heart Journal, The American Journal of Cardiology, Academic Emergency Medicine and European Heart Journal Acute Cardiovascular Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact